Article
Stim1 Polymorphism Disrupts Immune Signaling and Creates Renal Injury in Hypertension.
Journal of the American Heart Association - 3 Mar 2020
Dhande Isha S, Zhu Yaming, Kneedler Sterling C, Joshi Aniket S, Hicks M John, Wenderfer Scott E, Braun Michael C, Doris Peter A
Abstract excerpt
Background Spontaneously hypertensive rats of the stroke-prone line (SHR-A3) develop hypertensive renal disease as a result of naturally occurring genetic variation. Our prior work identified a single-nucleotide polymorphism unique to SHR-A3 that results in truncation of the carboxy terminus of STIM1. The SHR-B2 line, which is also hypertensive but resists hypertensive renal injury, expresses the wild-type STIM1....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
